102 related articles for article (PubMed ID: 27539058)
1. Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells.
Toro L; Bohovic R; Matuskova M; Smolkova B; Kucerova L
Stem Cells Dev; 2016 Nov; 25(21):1640-1651. PubMed ID: 27539058
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
[TBL] [Abstract][Full Text] [Related]
3. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
[TBL] [Abstract][Full Text] [Related]
4. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein.
Xing L; Deng X; Kotedia K; Ackerstaff E; Ponomarev V; Clifton Ling C; Koutcher JA; Li GC
Acta Oncol; 2008; 47(7):1211-20. PubMed ID: 18661431
[TBL] [Abstract][Full Text] [Related]
9. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
[TBL] [Abstract][Full Text] [Related]
11. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
12. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
[TBL] [Abstract][Full Text] [Related]
13. [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo].
Krasikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
Mol Biol (Mosk); 2015; 49(6):1007-15. PubMed ID: 26710783
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
15. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
16. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
[TBL] [Abstract][Full Text] [Related]
18. Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
Kucerova L; Poturnajova M; Tyciakova S; Matuskova M
Stem Cell Res; 2012 Mar; 8(2):247-58. PubMed ID: 22265744
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment.
Durinikova E; Plava J; Tyciakova S; Skvara P; Vojs Stanova A; Kozovska Z; Kucerova L; Matuskova M
Cancer Gene Ther; 2018 Dec; 25(11-12):285-299. PubMed ID: 29925898
[TBL] [Abstract][Full Text] [Related]
20. Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.
Zaoui K; Bossow S; Grossardt C; Leber MF; Springfeld C; Plinkert PK; Kalle Cv; Ungerechts G
Cancer Gene Ther; 2012 Mar; 19(3):181-91. PubMed ID: 22076043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
